CBIO EPS Estimates
Crescent Biopharma, Inc.
$13.18
-$0.31(-2.30%)
34
Overall
40
Value
36
Tech
28
Quality
Market Cap
$501.07M
Volume
13.81K
52W Range
$8.72 - $27.41
Target Price
$31.33
CBIO EPS estimates: the consensus estimate for Crescent Biopharma, Inc.'s current fiscal year is -$2.93 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CBIO EPS Estimates
- EPS estimate, current quarter
- $-0.72
- EPS estimate, next quarter
- $-0.75
- EPS estimate, current year
- $-2.93
- EPS estimate, next year
- $-3.17
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2024 | $-59.00 |
| 2023 | $-58.00 |
| 2022 | $-89.00 |
| 2021 | $-123.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CBIO | $13.18 | -2.3% | 13.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crescent Biopharma, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW